FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use - CNBC
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.
Comments